EGFR bi-armed autologous activated T cells - Barbara Ann Karmanos Cancer Institute
Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) - J&J
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42742405
 
Aarti Bhatia; Aastha Kapoor; Ajay Mehta; Ammar Sukari; Bhumsuk Keam; Emrullah Yilmaz; Ewa Pawlowska; Hsiang-Fong Kao; Hung-Ming Wang; Jin-Ching Lin; Joshua C Curtin; Kevin Harrington; Kiichiro Toyoizumi; Mahadi Baig; Malwinder S Sandhu; Marc Oliva; Mark Wade; Myung-Ju Ahn; Patricia Lorenzini; Paul L Swiecicki; Ranee Mehra; Remy B Verheijen; Sujay Shah; Sung-Bae Kim; William Ince; Xuesong Lyu; Zara Vidales
 
Sep 16, 2026
 
Next